Found: 174
Select item for more details and to access through your institution.
Improving Cost-effectiveness and Access to Cognitive Behavior Therapy for Depression: Providing Remote-Ready, Computer-Assisted Psychotherapy in Times of Crisis and Beyond.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Continuation phase treatment outcomes for switching, combining, or augmenting strategies for treatment‐resistant major depressive disorder: A VAST‐D report.
- Published in:
- Depression & Anxiety (1091-4269), 2021, v. 38, n. 2, p. 185, doi. 10.1002/da.23114
- By:
- Publication type:
- Article
Improvement of sexual functioning during treatment of MDD with adjunctive pimavanserin: A secondary analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS.
- Published in:
- Depression & Anxiety (1091-4269), 2015, v. 32, n. 8, p. 605, doi. 10.1002/da.22378
- By:
- Publication type:
- Article
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FIXED-DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER.
- Published in:
- Depression & Anxiety (1091-4269), 2015, v. 32, n. 6, p. 451, doi. 10.1002/da.22365
- By:
- Publication type:
- Article
CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER.
- Published in:
- Depression & Anxiety (1091-4269), 2014, v. 31, n. 3, p. 250, doi. 10.1002/da.22199
- By:
- Publication type:
- Article
PATIENT TREATMENT PREFERENCE AS A PREDICTOR OF RESPONSE AND ATTRITION IN TREATMENT FOR CHRONIC DEPRESSION.
- Published in:
- Depression & Anxiety (1091-4269), 2012, v. 29, n. 10, p. 896, doi. 10.1002/da.21977
- By:
- Publication type:
- Article
EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION.
- Published in:
- Depression & Anxiety (1091-4269), 2012, v. 29, n. 7, p. 574, doi. 10.1002/da.21970
- By:
- Publication type:
- Article
Income and attrition in the treatment of depression: a STAR*D report.
- Published in:
- Depression & Anxiety (1091-4269), 2009, v. 26, n. 7, p. 622, doi. 10.1002/da.20541
- By:
- Publication type:
- Article
Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
- Published in:
- Depression & Anxiety (1091-4269), 2008, v. 25, n. 12, p. 1060, doi. 10.1002/da.20467
- By:
- Publication type:
- Article
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study.
- Published in:
- International Journal of Neuropsychopharmacology, 2021, v. 24, n. 12, p. 965, doi. 10.1093/ijnp/pyab050
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 2, p. 313, doi. 10.1017/S1461145712000727
- By:
- Publication type:
- Article
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
- Published in:
- International Journal of Neuropsychopharmacology, 2009, v. 12, n. 4, p. 459, doi. 10.1017/S1461145708009073
- By:
- Publication type:
- Article
CBT MobileWork©: User-Centered Development and Testing of a Mobile Mental Health Application for Depression.
- Published in:
- Cognitive Therapy & Research, 2021, v. 45, n. 2, p. 287, doi. 10.1007/s10608-020-10159-4
- By:
- Publication type:
- Article
Dysfunctional Attitudes, Attributional Styles, and Phase of Illness in Bipolar Disorder.
- Published in:
- Cognitive Therapy & Research, 2010, v. 34, n. 1, p. 24, doi. 10.1007/s10608-008-9218-6
- By:
- Publication type:
- Article
Effectiveness of St. John's Wort in Major Depression.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 285, n. 15, p. 1978, doi. 10.1001/jama.285.15.1978
- By:
- Publication type:
- Article
Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy.
- Published in:
- JAMA: Journal of the American Medical Association, 2001, v. 285, n. 10, p. 1299, doi. 10.1001/jama.285.10.1299
- By:
- Publication type:
- Article
Atypical Depression in the 21st Century: Diagnostic and Treatment Issues.
- Published in:
- Psychiatric Times, 2011, v. 28, n. 1, p. 42
- By:
- Publication type:
- Article
Combining High-Yield CBT Methods and Pharmacotherapy in Brief Sessions.
- Published in:
- Psychiatric Times, 2010, v. 27, n. 10, p. 24
- By:
- Publication type:
- Article
Improving Recognition and Treatment of Bipolar Depression: Perennial Problems and Newer Strategies.
- Published in:
- Psychiatric Times, 2007, v. 24, p. 23
- By:
- Publication type:
- Article
Cognitive Behavioral Therapy for Clinicians.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
Combining Cognitive Therapy and Medication for Mood Disorders.
- Published in:
- Psychiatric Annals, 2006, v. 36, n. 5, p. 320, doi. 10.3928/00485713-20060501-01
- By:
- Publication type:
- Article
Pharmacologic Strategies for Treatment-resistant Depression An Update on the State of the Evidence.
- Published in:
- Psychiatric Annals, 2005, v. 35, n. 12, p. 970, doi. 10.3928/00485713-20051201-04
- By:
- Publication type:
- Article
What is the State of the Evidence?
- Published in:
- Psychiatric Annals, 2003, v. 33, n. 12, p. 813, doi. 10.3928/0048-5713-20031201-08
- By:
- Publication type:
- Article
EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S208, doi. 10.1093/schbul/sbaa030.503
- By:
- Publication type:
- Article
Outcomes of Acute Phase Cognitive Therapy in Outpatients with Anxious versus Nonanxious Depression.
- Published in:
- Psychotherapy & Psychosomatics, 2012, v. 81, n. 3, p. 153, doi. 10.1159/000334909
- By:
- Publication type:
- Article
Citalopram treatment of paroxetine-intolerant depressed patients.
- Published in:
- Depression & Anxiety (1091-4269), 2002, v. 16, n. 3, p. 128, doi. 10.1002/da.10055
- By:
- Publication type:
- Article
Venlafaxine and treatment-resistant depression.
- Published in:
- Depression & Anxiety (1091-4269), 2000, v. 12, p. 55, doi. 10.1002/1520-6394(2000)12:1+<55::AID-DA7>3.0.CO;2-X
- By:
- Publication type:
- Article
Psychotherapy of refractory depressions.
- Published in:
- Depression & Anxiety (1091-4269), 1997, v. 5, n. 4, p. 190, doi. 10.1002/(SICI)1520-6394(1997)5:4<190::AID-DA5>3.0.CO;2-H
- By:
- Publication type:
- Article
Bipolar depression: An underestimated treatment challenge.
- Published in:
- Depression & Anxiety (1091-4269), 1997, v. 5, n. 2, p. 73, doi. 10.1002/(SICI)1520-6394(1997)5:2<73::AID-DA3>3.0.CO;2-6
- By:
- Publication type:
- Article
Pacientų, sergančių depresiniu sutrikimu gydymo antidepresnatais nepageidaujamų reiškinių stebėsena: tarptautinis sutarimas.
- Published in:
- Biological Psychiatry & Psychopharmacology / Biologinė Psichiatrija ir Psichofarmakologija, 2020, v. 22, n. 2, p. 59
- By:
- Publication type:
- Article
HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana.
- Published in:
- AIDS & Behavior, 2018, v. 22, n. 5, p. 1503, doi. 10.1007/s10461-017-1878-3
- By:
- Publication type:
- Article
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Large-Scale Study Suggests Specific Indicators for Combined Cognitive Therapy and Pharmacotherapy in Major Depressive Disorder.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo.
- Published in:
- JAMA Psychiatry, 2013, v. 70, n. 11, p. 1152, doi. 10.1001/jamapsychiatry.2013.1969
- By:
- Publication type:
- Article
Why Has the Antidepressant–Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades?
- Published in:
- CNS Neuroscience & Therapeutics, 2010, v. 16, n. 4, p. 217, doi. 10.1111/j.1755-5949.2010.00151.x
- By:
- Publication type:
- Article
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide.
- Published in:
- Psychopharmacology Bulletin, 2024, v. 54, n. 1, p. 8
- By:
- Publication type:
- Article
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder.
- Published in:
- Psychopharmacology Bulletin, 2021, v. 51, n. 2, p. 8
- By:
- Publication type:
- Article
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 4, p. 8
- By:
- Publication type:
- Article
Commentary on the Hamilton Rating Scale for Depression: 60+ Years Old and Still Relevant to the Assessment of Antidepressant Treatment Outcomes.
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 2, p. 154
- By:
- Publication type:
- Article
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).
- Published in:
- Psychopharmacology Bulletin, 2022, v. 52, n. 1, p. 68
- By:
- Publication type:
- Article
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study.
- Published in:
- Psychopharmacology Bulletin, 2021, v. 51, n. 4, p. 8
- By:
- Publication type:
- Article
Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression.
- Published in:
- Psychopharmacology Bulletin, 2021, v. 51, n. 3, p. 50
- By:
- Publication type:
- Article
Patient Response Trajectories in Major Depressive Disorder.
- Published in:
- Psychopharmacology Bulletin, 2020, v. 50, n. 4, p. 8
- By:
- Publication type:
- Article
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Psychopharmacology Bulletin, 2018, v. 48, n. 4, p. 62
- By:
- Publication type:
- Article
Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study.
- Published in:
- Psychopharmacology Bulletin, 2009, v. 42, n. 3, p. 1
- By:
- Publication type:
- Article